406 related articles for article (PubMed ID: 16842188)
21. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
Slayden RA; Lee RE; Barry CE
Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
[TBL] [Abstract][Full Text] [Related]
22. Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis.
Tonge PJ; Kisker C; Slayden RA
Curr Top Med Chem; 2007; 7(5):489-98. PubMed ID: 17346194
[TBL] [Abstract][Full Text] [Related]
23. Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor.
Lei B; Wei CJ; Tu SC
J Biol Chem; 2000 Jan; 275(4):2520-6. PubMed ID: 10644708
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach.
Chollet A; Mourey L; Lherbet C; Delbot A; Julien S; Baltas M; Bernadou J; Pratviel G; Maveyraud L; Bernardes-Génisson V
J Struct Biol; 2015 Jun; 190(3):328-37. PubMed ID: 25891098
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.
Schroeder EK; Basso LA; Santos DS; de Souza ON
Biophys J; 2005 Aug; 89(2):876-84. PubMed ID: 15908576
[TBL] [Abstract][Full Text] [Related]
27. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II.
Marrakchi H; Lanéelle G; Quémard AK
Microbiology (Reading); 2000 Feb; 146 ( Pt 2)():289-296. PubMed ID: 10708367
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
Zhu C; Liu Y; Hu L; Yang M; He ZG
J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
[TBL] [Abstract][Full Text] [Related]
29. Pharmacophore mapping, molecular docking, chemical synthesis of some novel pyrrolyl benzamide derivatives and evaluation of their inhibitory activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Joshi SD; Dixit SR; Basha J; Kulkarni VH; Aminabhavi TM; Nadagouda MN; Lherbet C
Bioorg Chem; 2018 Dec; 81():440-453. PubMed ID: 30223149
[TBL] [Abstract][Full Text] [Related]
30. Direct inhibitors of InhA are active against Mycobacterium tuberculosis.
Manjunatha UH; S Rao SP; Kondreddi RR; Noble CG; Camacho LR; Tan BH; Ng SH; Ng PS; Ma NL; Lakshminarayana SB; Herve M; Barnes SW; Yu W; Kuhen K; Blasco F; Beer D; Walker JR; Tonge PJ; Glynne R; Smith PW; Diagana TT
Sci Transl Med; 2015 Jan; 7(269):269ra3. PubMed ID: 25568071
[TBL] [Abstract][Full Text] [Related]
31. Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.
Vilchèze C; Baughn AD; Tufariello J; Leung LW; Kuo M; Basler CF; Alland D; Sacchettini JC; Freundlich JS; Jacobs WR
Antimicrob Agents Chemother; 2011 Aug; 55(8):3889-98. PubMed ID: 21628538
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
33. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
[TBL] [Abstract][Full Text] [Related]
34. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
[TBL] [Abstract][Full Text] [Related]
35. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
[TBL] [Abstract][Full Text] [Related]
36. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
Unissa AN; Subbian S; Hanna LE; Selvakumar N
Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
[TBL] [Abstract][Full Text] [Related]
37. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
Tripathi A; Wadia N; Bindal D; Jana T
Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
[TBL] [Abstract][Full Text] [Related]
38. Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.
Nguyen M; Quémard A; Broussy S; Bernadou J; Meunier B
Antimicrob Agents Chemother; 2002 Jul; 46(7):2137-44. PubMed ID: 12069966
[TBL] [Abstract][Full Text] [Related]
39. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis.
Quémard A; Sacchettini JC; Dessen A; Vilcheze C; Bittman R; Jacobs WR; Blanchard JS
Biochemistry; 1995 Jul; 34(26):8235-41. PubMed ID: 7599116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
